The histological diagnosis of metastases to the breast from extramammary malignancies

This study aims to review histological and immunohistochemical features that are useful in the diagnosis of metastases to the breast. Histological features were compared between non-haematological metastases to the breast and 100 consecutive core biopsy specimens of primary invasive carcinomas of the breast. 18 non-haematological metastases to the breast were diagnosed over a 10-year period (0.3% of malignant mammary tumours). Elastosis and carcinoma in situ were seen only in primary mammary cancers. Two-thirds of tumours had features raising the possibility of metastasis, such as clear cell carcinoma suggestive of renal origin and small cell carcinoma suggestive of pulmonary origin. The features observed in haematological metastases are also described. Immunohistochemical panels to distinguish mammary carcinoma (oestrogen receptor, gross cystic fluid protein-15) from common metastases to the breast, including carcinoma of the lung (thyroid transcription factor-1), malignant melanoma (S100, HMB45, melan-A) and ovarian serous papillary carcinoma (Wilms’ tumour 1), are discussed. The pathologist has a key role in considering the diagnosis of metastasis to the breast if the histological features are unusual for a primary mammary tumour. The clinical history is vital in some cases. Immunohistochemistry plays a useful supplementary role.

[1]  D. Easton,et al.  Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast , 2006, Histopathology.

[2]  S. Badve.  Chapter 26 – Other Malignant Lesions of the Breast , 2006 .

[3]  N. Jhala,et al.  Non-Hodgkin's lymphoma of the breast: a review of 18 primary and secondary cases. , 2006, Annals of diagnostic pathology.

[4]  I. Fentiman,et al.  Different patterns of inflammation and prognosis in invasive carcinoma of the breast , 2006, Histopathology.

[5]  P. Chu,et al.  Immunohistochemical Expression of Estrogen Receptor in Pulmonary Adenocarcinoma , 2006, Applied immunohistochemistry & molecular morphology : AIMM.

[6]  J. Robertson,et al.  Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation , 2006, The Journal of pathology.

[7]  C. Perou,et al.  Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma , 2006, Modern Pathology.

[8]  Y. Natkunam,et al.  Utility of Syndecan-1 (CD138) Expression in the Diagnosis of Undifferentiated Malignant Neoplasms: A Tissue Microarray Study of 1,754 Cases , 2005, Applied immunohistochemistry & molecular morphology : AIMM.

[9]  L. Norton,et al.  Expression of WT1, CA 125, and GCDFP-15 as Useful Markers in the Differential Diagnosis of Primary Ovarian Carcinomas Versus Metastatic Breast Cancer to the Ovary , 2005, The American journal of surgical pathology.

[10]  J. Komorowski,et al.  Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm , 2005, Clinical Cancer Research.

[11]  R. Odze,et al.  Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. , 2005, Archives of pathology & laboratory medicine.

[12]  J. Peterse,et al.  Expression of oestrogen receptor and loss of E‐cadherin are diagnostic for gastric metastasis of breast carcinoma , 2005, Histopathology.

[13]  V. Speirs,et al.  Expression of prostate specific antigen in male breast cancer , 2004, Journal of Clinical Pathology.

[14]  C. Gomez-Fernandez,et al.  Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. , 2005, American journal of clinical pathology.

[15]  A. Malpica,et al.  Serous Carcinoma of the Ovary and Peritoneum With Metastases to the Breast and Axillary Lymph Nodes: A Potential Pitfall , 2004, The American journal of surgical pathology.

[16]  A. Cochran,et al.  Is MAGE-1 Expression in Metastatic Malignant Melanomas Really Helpful? , 2004, The American journal of surgical pathology.

[17]  C. Manivel,et al.  Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. , 2004, American journal of clinical pathology.

[18]  A. Gown,et al.  Wilms Tumor Gene Product: Sensitive and Contextually Specific Marker of Serous Carcinomas of Ovarian Surface Epithelial Origin , 2004, Applied immunohistochemistry & molecular morphology : AIMM.

[19]  I. Ellis,et al.  Expression of luminal and basal cytokeratins in human breast carcinoma , 2004, The Journal of pathology.

[20]  P. Rehak,et al.  Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors. , 2004, The Journal of urology.

[21]  S. Badve,et al.  Expression of androgen receptor and prostate-specific antigen in male breast carcinoma , 2003, Breast Cancer Research.

[22]  N. Ordóñez,et al.  Application of Mesothelin Immunostaining in Tumor Diagnosis , 2003, The American journal of surgical pathology.

[23]  I. Ellis,et al.  An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. , 2003, Human pathology.

[24]  C. Moskaluk,et al.  Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays , 2003, Modern Pathology.

[25]  J. Bosq,et al.  Primary Breast Lymphoma , 2003, Leukemia & lymphoma.

[26]  C. Moskaluk,et al.  Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. , 2003, Human pathology.

[27]  A. Gown,et al.  CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas , 2003, The American journal of surgical pathology.

[28]  I. Ellis,et al.  Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast Carcinoma , 2003, The American journal of surgical pathology.

[29]  S. Kim,et al.  Immunohistochemical Profile of Common Epithelial Neoplasms Arising in the Kidney , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[30]  M. Varma,et al.  Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology. , 2002, American journal of clinical pathology.

[31]  G. Pinkus,et al.  WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. , 2002, American journal of clinical pathology.

[32]  P. Chu,et al.  Keratin expression in human tissues and neoplasms , 2002, Histopathology.

[33]  M. Kuroda,et al.  Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome , 2002, Virchows Archiv.

[34]  D. Fisher,et al.  Role for Microphthalmia Transcription Factor in the Diagnosis of Metastatic Malignant Melanoma , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[35]  T. Tot.  Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. , 2002, European journal of cancer.

[36]  L. Truong,et al.  Diagnosing Primary and Metastatic Renal Cell Carcinoma: The Use of the Monoclonal Antibody `Renal Cell Carcinoma Marker' , 2001, The American journal of surgical pathology.

[37]  R. Odze,et al.  Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. , 2001, Human pathology.

[38]  N. Goldstein,et al.  WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. , 2001, American journal of clinical pathology.

[39]  M. Papotti,et al.  Expression of Apocrine Differentiation Markers in Neuroendocrine Breast Carcinomas of Aged Women , 2001, Modern Pathology.

[40]  S. Shin,et al.  Small cell carcinoma of the breast--additional immunohistochemical studies. , 2001, The American journal of surgical pathology.

[41]  I. Vizcaíno,et al.  Metastasis to the breast from extramammary malignancies: a report of four cases and a review of literature , 2001, European Radiology.

[42]  K. Franssila,et al.  Microphthalmia Transcription Factor in the Immunohistochemical Diagnosis of Metastatic Melanoma: Comparison With Four Other Melanoma Markers , 2001, The American journal of surgical pathology.

[43]  A. Vincent-Salomon,et al.  High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases , 2000, Histopathology.

[44]  N. Goldstein,et al.  Colon Signet Ring Cell Adenocarcinoma: Immunohistochemical Characterization and Comparison with Gastric and Typical Colon Adenocarcinomas , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[45]  Sandra J Shin,et al.  Small Cell Carcinoma of the Breast: A Clinicopathologic and Immunohistochemical Study of Nine Patients , 2000, The American journal of surgical pathology.

[46]  D. Barnes,et al.  Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening , 2000, Journal of clinical pathology.

[47]  M. Wick,et al.  Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach. , 2000, Seminars in diagnostic pathology.

[48]  Z. Gatalica,et al.  Immunohistochemical localization of prostate-specific antigen in ductal epithelium of male breast. Potential diagnostic pitfall in patients with gynecomastia. , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[49]  F. Tavassoli,et al.  T-Cell Lymphoma Presenting in the Breast: A Histologic, Immunophenotypic and Molecular Genetic Study of Four Cases , 2000, Modern Pathology.

[50]  Dietel,et al.  Expression of thyroid transcription factor‐1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites , 2000, Histopathology.

[51]  Harris,et al.  Morphological and immunophenotypic variations in malignant melanoma , 2000, Histopathology.

[52]  W. Moon,et al.  Metastatic tumors to the breast: mammographic and ultrasonographic findings. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[53]  N. Ordóñez,et al.  Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. , 2000, The American journal of surgical pathology.

[54]  M. Rubin,et al.  Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. , 2000, American journal of clinical pathology.

[55]  P. Chu,et al.  Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. , 2000, American journal of clinical pathology.

[56]  Dietel,et al.  Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B , 2000, Histopathology.

[57]  T. Tot.  Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases. , 1999, Annals of diagnostic pathology.

[58]  A. Renshaw,et al.  Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease. , 1999, American journal of clinical pathology.

[59]  N. Shetty-Alva,et al.  An update of tumor metastasis to the breast data. , 1999, Archives of surgery.

[60]  P. V. van Diest,et al.  Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. , 1999, Journal of clinical pathology.

[61]  M. Dietel,et al.  Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. , 1997, Human pathology.

[62]  S. Banerjee,et al.  VS38 immunostaining in neuroendocrine tumours , 1997, Histopathology.

[63]  M. Dietel,et al.  Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites , 1996, Histopathology.

[64]  R. Lauro,et al.  Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[65]  J. Shanks,et al.  VS38 immunostaining in melanocytic lesions. , 1996, Journal of clinical pathology.

[66]  C. Scott-Conner,et al.  Diagnosis and natural history of extramammary tumors metastatic to the breast. , 1994, Journal of the American College of Surgeons.

[67]  D. Poller.  Prostate marker immunoreactivity in salivary gland neoplasms. , 1994, The American journal of surgical pathology.

[68]  I. Fleming,et al.  Breast malignancy in children. , 1993, Journal of pediatric surgery.

[69]  J. Krieken.  Prostate Marker Immunoreactivity in Salivary Gland Neoplasms: A Rare Pitfall in Immunohistochemistry , 1993 .

[70]  J. V. van Krieken.  Prostate Marker Immunoreactivity in Salivary Gland Neoplasms: A Rare Pitfall in Immunohistochemistry , 1993, The American journal of surgical pathology.

[71]  G. Viale,et al.  Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin , 1992, Cancer.

[72]  J. Quesenberry,et al.  Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases. , 1992, American journal of clinical pathology.

[73]  R. Whitehead,et al.  Effects of Cholera Toxin on Human Colon Carcinoma Cell Lines , 1992, Pathology.

[74]  J. Coindre,et al.  Metastases to the breast: Differential diagnosis from primary breast carcinoma , 1991, Journal of surgical oncology.

[75]  S. Poppema,et al.  Primary breast lymphoma: An immunohistologic study of 20 new cases , 1990 .

[76]  L. Bobrow,et al.  S100 protein in human mammary tissue—immunoreactivity in breast carcinoma, including Paget's disease of the nipple, and value as a marker of myoepithelial cells , 1990, The Journal of pathology.

[77]  M. Amichetti,et al.  Metastases to the breast from extramammary malignancies. , 1990, Oncology.

[78]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[79]  I. Ellis,et al.  Carcinoembryonic antigen immunocytochemistry in primary breast cancer , 1989, Cancer.

[80]  N. Sneige,et al.  Fine-needle aspiration cytology of metastatic neoplasms in the breast. , 1989, American journal of clinical pathology.

[81]  M. Wick,et al.  Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. , 1989, Human pathology.

[82]  L. Wold,et al.  Lesions of the breast in children exclusive of typical fibroadenoma and gynecomastia. A clinicopathologic study of 113 cases. , 1989, Pathology annual.

[83]  A. Lee,et al.  S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry. , 1987, Human pathology.

[84]  Paul J. Kurtin,et al.  Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. , 1985, Human pathology.

[85]  E. McCrea,et al.  Metastases to the breast. , 1983, AJR. American journal of roentgenology.

[86]  L. Bassett,et al.  Breast metastases from extramammary malignancies. , 1982, Radiology.

[87]  M. Nielsen,et al.  Metastases to the breast from extramammary carcinomas. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[88]  M. Nadji,et al.  Prostatic origin of tumors. An immunohistochemical study. , 1980, American journal of clinical pathology.

[89]  L. Kalisher,et al.  Metastatic disease to the breast: clinical, pathologic, and radiographic features. , 1977, AJR. American journal of roentgenology.

[90]  W. P. Greening,et al.  Metastatic carcinoma within the breast. , 1976, Clinical oncology.

[91]  O. Ha,et al.  Metastatic neoplasms in the breast. , 1974 .

[92]  H. Oberman,et al.  Metastatic neoplasms in the breast. , 1974, Surgery, gynecology & obstetrics.

[93]  J. Urban,et al.  Cancers metastatic to the breast , 1972, Cancer.

[94]  A. Sandison,et al.  Metastatic tumours in the breast , 1959, The British journal of surgery.